Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine
Wu Y, Deng Y, Angelov B, Angelova A.
FASEB Bioadv. 2025 Jun 4;7(8):e70028. doi: 10.1096/fba.2025-00010. eCollection 2025 Aug.